Adriamycin-induced heart failure: mechanisms and modulation
Top Cited Papers
- 1 January 2000
- journal article
- review article
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 207 (1/2) , 77-86
- https://doi.org/10.1023/a:1007094214460
Abstract
Adriamycin (doxorubicin) is one of the most effective chemotherapeutic agents against a variety of cancers, but its usefulness is seriously curtailed by the risk of developing heart failure....Keywords
This publication has 95 references indexed in Scilit:
- Combination therapy with probucol prevents adriamycin-induced cardiomyopathyJournal of Molecular and Cellular Cardiology, 1995
- Probucol scavenged 1,1-diphenyl-2-picrylhydrazyl radicals and inhibited formation of thiobarbituric acid reactive substancesFree Radical Biology & Medicine, 1994
- Anthracycline Antibiotics in Cancer TherapyDrugs, 1994
- Probucol: Pharmacology and Clinical ApplicationThe Journal of Clinical Pharmacology, 1990
- Direct detection of paramagnetic species in adriamycin perfused rat heartsBiochemical and Biophysical Research Communications, 1988
- Refractory heart failure and age-related differences in adriamycin-induced myocardial changes in ratsCanadian Journal of Physiology and Pharmacology, 1987
- Prevention of doxorubicin cardiac toxicity in the mouse by N-acetylcysteine.Journal of Clinical Investigation, 1981
- Acute and Chronic Cardiovascular Effects of Doxorubicin in the DogJournal of Cardiovascular Pharmacology, 1980
- Glutathione peroxidase activity and selenium concentration in the hearts of doxorubicin-treated rabbitsJournal of Molecular and Cellular Cardiology, 1978
- Adriamycin: The Role of Lipid Peroxidation in Cardiac Toxicity and Tumor ResponseScience, 1977